|TNM classification of malignant tumours|
LH Sobin, MK Gospodarowicz, C Wittekind
John Wiley & Sons, 2011
|Alleviating the access abyss in palliative care and pain relief—an imperative of universal health coverage: the Lancet Commission report|
FM Knaul, PE Farmer, EL Krakauer, L De Lima, A Bhadelia, XJ Kwete, ...
The Lancet 391 (10128), 1391-1454, 2018
|Second cancers among 40 576 testicular cancer patients: focus on long-term survivors|
LB Travis, SD Fosså, SJ Schonfeld, ML McMaster, CF Lynch, H Storm, ...
Journal of the National Cancer Institute 97 (18), 1354-1365, 2005
|Expanding global access to radiotherapy|
R Atun, DA Jaffray, MB Barton, F Bray, M Baumann, B Vikram, TP Hanna, ...
The lancet oncology 16 (10), 1153-1186, 2015
|Expansion of cancer care and control in countries of low and middle income: a call to action|
P Farmer, J Frenk, FM Knaul, LN Shulman, G Alleyne, L Armstrong, ...
The Lancet 376 (9747), 1186-1193, 2010
|Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma|
LE Abrey, TT Batchelor, AJM Ferreri, M Gospodarowicz, EJ Pulczynski, ...
Journal of clinical oncology 23 (22), 5034-5043, 2005
|Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease|
LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ...
Jama 290 (4), 465-475, 2003
|Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis|
P Warde, L Specht, A Horwich, T Oliver, T Panzarella, M Gospodarowicz, ...
Journal of clinical oncology 20 (22), 4448-4452, 2002
|Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma|
A Rohatiner, F d'Amore, B Coiffier, D Crowther, M Gospodarowicz, ...
Annals of Oncology 5 (5), 397-400, 1994
|Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease|
LB Travis, M Gospodarowicz, RE Curtis, E Aileen Clarke, M Andersson, ...
Journal of the National Cancer Institute 94 (3), 182-192, 2002
|Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years|
GM Dores, C Metayer, RE Curtis
Oncology Times 24 (12), 89-90, 2002
|Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial|
P Warde, M Mason, K Ding, P Kirkbride, M Brundage, R Cowan, ...
The Lancet 378 (9809), 2104-2111, 2011
|Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue|
E Zucca, A Conconi, E Pedrinis, S Cortelazzo, T Motta, ...
Blood, The Journal of the American Society of Hematology 101 (7), 2489-2495, 2003
|Risk of second malignant neoplasms among long-term survivors of testicular cancer|
LB Travis, RE Curtis, JF Fraumeni Jr, JD Boice Jr, H Storm, M Andersson, ...
Journal of the National Cancer Institute 89 (19), 1429-1439, 1997
|The TNM classification of prostate cancer|
FH SchrlSder, P Hermanek, L Denis, WR Fair, MK Gospodarowicz
The Prostate 4, 129-138, 1992
|Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.|
CM Coppin, MK Gospodarowicz, K James, IF Tannock, B Zee, J Carson, ...
Journal of clinical oncology 14 (11), 2901-2907, 1996
|Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group|
E Zucca, A Conconi, TI Mughal, AH Sarris, JF Seymour, U Vitolo, R Klasa, ...
Journal of Clinical Oncology 21 (1), 20-27, 2003
|Intermittent androgen suppression for rising PSA level after radiotherapy|
JM Crook, CJ O'Callaghan, G Duncan, DP Dearnaley, CS Higano, ...
New England Journal of Medicine 367 (10), 895-903, 2012
|The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma|
RW Tsang, JD Brierley, WJ Simpson, T Panzarella, MK Gospodarowicz, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 1998
|Treatment of metastatic prostatic cancer with low-dose prednisone: evaluation of pain and quality of life as pragmatic indices of response.|
I Tannock, M Gospodarowicz, W Meakin, T Panzarella, L Stewart, W Rider
Journal of Clinical Oncology 7 (5), 590-597, 1989